Emerson Electric Co. (LON:0R33)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is October - September.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 8, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Market Capitalization	55,364	46,684	45,226	38,854	41,708	30,301
Market Cap Growth	9.77%	3.22%	16.40%	-6.84%	37.65%	-9.38%
Enterprise Value	64,736	57,396	49,060	52,832	45,425	34,423
Last Close Price	97.80	79.99	76.80	62.50	64.65	47.88
PE Ratio	28.59	31.79	4.18	13.40	24.45	19.94
PS Ratio	4.27	3.58	3.64	3.14	4.36	2.33
PB Ratio	3.81	2.28	2.08	2.65	5.68	4.64
P/FCF Ratio	27.67	21.48	201.42	16.51	17.76	15.40
P/OCF Ratio	23.91	18.78	86.64	14.82	15.75	12.71
EV/Sales Ratio	4.92	4.40	3.95	4.26	4.74	2.65
EV/EBITDA Ratio	16.94	16.67	15.47	18.27	22.77	12.45
EV/EBIT Ratio	25.58	25.50	20.62	23.87	30.21	15.70
EV/FCF Ratio	32.36	26.41	218.50	22.44	19.34	17.49
Debt / Equity Ratio	0.75	0.30	0.33	0.66	0.73	0.95
Debt / EBITDA Ratio	2.88	1.72	2.13	3.17	2.50	2.10
Debt / FCF Ratio	5.43	2.87	31.77	4.12	2.28	3.15
Asset Turnover	0.40	0.40	0.39	0.46	0.54	0.77
Inventory Turnover	3.66	4.00	4.13	3.96	3.62	5.13
Quick Ratio	0.59	1.32	2.28	0.65	0.94	1.14
Current Ratio	0.85	1.78	2.75	1.09	1.35	1.52
Return on Equity (ROE)	9.16%	5.93%	10.54%	14.35%	15.42%	23.80%
Return on Assets (ROA)	4.85%	4.33%	4.63%	5.10%	5.33%	8.17%
Return on Capital (ROIC)	5.92%	5.30%	5.81%	6.96%	7.55%	11.64%
Return on Capital Employed (ROCE)	10.80%	7.80%	7.70%	8.80%	11.00%	16.60%
Earnings Yield	3.50%	3.15%	23.95%	7.46%	4.09%	5.01%
FCF Yield	3.61%	4.66%	0.50%	6.06%	5.63%	6.49%
Dividend Yield	1.24%	1.96%	2.22%	2.96%	2.31%	3.23%
Payout Ratio	45.04%	61.03%	9.06%	37.85%	52.54%	61.53%
Buyback Yield / Dilution	0.97%	0.57%	3.19%	0.91%	0.79%	2.26%
Total Shareholder Return	2.21%	2.53%	5.41%	3.87%	3.10%	5.49%

Updated Feb 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.